Long non-coding RNA LOC554202 promotes acquired gefitinib resistance in non-small cell lung cancer through upregulating miR-31 expression

In conclusion, these data will help us develop potential therapeutic targets for the diagnosis and treatment of acquired EGFR TKI resistance in EGFR-mutant NSCLC.

http://www.jcancer.org/v10p6003.htm

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Jing He, Shidai Jin, Wei Zhang, Deqin Wu, Jun Li, Jing Xu, Wen Gao Tags: Research Paper Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Study